Consistently, immunoblotting showed that the cleaved caspase-3, an apoptosis-associated protein marker, was up-regulated in both ICC cell lines, and the oncoprotein Bcl-2 was down-regulated in RBE cells after CB treatment (24–26) (Figure 1J). Here, BCL2 is linked to intrahepatic cholangiocarcinoma.